Mode
Text Size
Log in / Sign up

Common Variable Immunodeficiency

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Common Variable Immunodeficiency

7 trials tracked for Common Variable Immunodeficiency: 6 in phase 3 or 4 and 1 with published results. The most-cited published study has 2 citations.

7Trials tracked
6Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 4 Phase 2 1
  1. Phase 3 Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases Completed · 2 cited
  2. Phase 4 A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency Completed
  3. Phase 4 Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency Completed
  4. Phase 3 Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases Completed
  5. Phase 3 Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Completed
  6. Phase 3 Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy Completed
Show 1 more trials
  1. Phase 2 Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation Completed

Showing the 7 most-cited and recently-updated of 7 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.